Breakthrough trial aims to free hepatitis b patients from lifelong medication

NCT ID NCT05630807

Summary

This large Phase 3 study is testing whether an investigational drug called bepirovirsen can provide a 'functional cure' for people with chronic Hepatitis B. It involves nearly 1,000 participants who are already on standard antiviral medication. The main goal is to see if adding bepirovirsen for 24 weeks can suppress the virus enough that patients can safely stop all treatments and remain healthy long-term.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GSK Investigational Site

    Chandler, Arizona, 85224, United States

  • GSK Investigational Site

    Davis, California, 95817, United States

  • GSK Investigational Site

    Los Angeles, California, 90027, United States

  • GSK Investigational Site

    Palo Alto, California, 94304, United States

  • GSK Investigational Site

    San Jose, California, 95128, United States

  • GSK Investigational Site

    Littleton, Colorado, 80120, United States

  • GSK Investigational Site

    Miami, Florida, 33134, United States

  • GSK Investigational Site

    Iowa City, Iowa, 52242, United States

  • GSK Investigational Site

    Baltimore, Maryland, 21287, United States

  • GSK Investigational Site

    Detroit, Michigan, 48377, United States

  • GSK Investigational Site

    Richmond, Virginia, 23219, United States

  • GSK Investigational Site

    Richmond, Virginia, 23249, United States

  • GSK Investigational Site

    Buenos Aires, 1061, Argentina

  • GSK Investigational Site

    Buenos Aires, C1061AAS, Argentina

  • GSK Investigational Site

    Buenos Aires, C1125ABE, Argentina

  • GSK Investigational Site

    Capital Federal, C1181ACI, Argentina

  • GSK Investigational Site

    Pilar, B1629AHJ, Argentina

  • GSK Investigational Site

    Rosario, S2002KDT, Argentina

  • GSK Investigational Site

    Aracaju, 49060-010, Brazil

  • GSK Investigational Site

    Campinas, 13034-685, Brazil

  • GSK Investigational Site

    Curitiba, 80810-050, Brazil

  • GSK Investigational Site

    Manaus, 69040-000, Brazil

  • GSK Investigational Site

    Porto Alegre, 90035003, Brazil

  • GSK Investigational Site

    Santa Maria, 97105-900, Brazil

  • GSK Investigational Site

    São Paulo, 05403-000, Brazil

  • GSK Investigational Site

    São Paulo, 08270-070, Brazil

  • GSK Investigational Site

    Vila Mariana, 04121-000, Brazil

  • GSK Investigational Site

    Sofia, 1431, Bulgaria

  • GSK Investigational Site

    Sofia, 1606, Bulgaria

  • GSK Investigational Site

    Sofia, Bulgaria

  • GSK Investigational Site

    Veliko Tarnovo, 5000, Bulgaria

  • GSK Investigational Site

    Vancouver, British Columbia, V6Z 2K5, Canada

  • GSK Investigational Site

    Victoria, British Columbia, V8V 3M9, Canada

  • GSK Investigational Site

    Ottawa, Ontario, K1H 8L6, Canada

  • GSK Investigational Site

    Toronto, Ontario, M5G 2C4, Canada

  • GSK Investigational Site

    Montreal, Quebec, H2X 0A9, Canada

  • GSK Investigational Site

    Montreal, Quebec, H4A 3J1, Canada

  • GSK Investigational Site

    Québec, Quebec, G1V 4G2, Canada

  • GSK Investigational Site

    Saint-Jérôme, Quebec, J7Z 2V4, Canada

  • GSK Investigational Site

    Beijing, 100015, China

  • GSK Investigational Site

    Beijing, 100050, China

  • GSK Investigational Site

    Beijing, China

  • GSK Investigational Site

    Changchun, 130021, China

  • GSK Investigational Site

    Chengdu, China

  • GSK Investigational Site

    Chongqing, 400042, China

  • GSK Investigational Site

    Fuzhou, 350025, China

  • GSK Investigational Site

    Guangzhou, 510060, China

  • GSK Investigational Site

    Guangzhou, 510515, China

  • GSK Investigational Site

    Guangzhou, 510630, China

  • GSK Investigational Site

    Hangzhou, 310000, China

  • GSK Investigational Site

    Hangzhou, 310003, China

  • GSK Investigational Site

    Kunming, 650021, China

  • GSK Investigational Site

    Nanjing, 210008, China

  • GSK Investigational Site

    Shanghai, 200025, China

  • GSK Investigational Site

    Shanghai, 200040, China

  • GSK Investigational Site

    Shanghai, 201506, China

  • GSK Investigational Site

    Shenyang, 110022, China

  • GSK Investigational Site

    Shenzhen, 518023, China

  • GSK Investigational Site

    Ürümqi, 830054, China

  • GSK Investigational Site

    Wuhan, 430022, China

  • GSK Investigational Site

    Xi'an, 710061, China

  • GSK Investigational Site

    Zhengzhou, 450000, China

  • GSK Investigational Site

    Zhenjiang, China

  • GSK Investigational Site

    Clermont-Ferrand, 63003, France

  • GSK Investigational Site

    Clichy, 92118, France

  • GSK Investigational Site

    Dijon, 21079, France

  • GSK Investigational Site

    Lille, 59037, France

  • GSK Investigational Site

    Pessac, 33604, France

  • GSK Investigational Site

    Poitiers, 86021, France

  • GSK Investigational Site

    Rennes, 35033, France

  • GSK Investigational Site

    Strasbourg, 67091, France

  • GSK Investigational Site

    Toulouse, 31059, France

  • GSK Investigational Site

    Berlin, 10243, Germany

  • GSK Investigational Site

    Berlin, 10439, Germany

  • GSK Investigational Site

    Berlin, 10787, Germany

  • GSK Investigational Site

    Berlin, 12163, Germany

  • GSK Investigational Site

    Bochum, 44787, Germany

  • GSK Investigational Site

    Cologne, 50668, Germany

  • GSK Investigational Site

    Düsseldorf, 40225, Germany

  • GSK Investigational Site

    München, 80336, Germany

  • GSK Investigational Site

    Athens, 10676, Greece

  • GSK Investigational Site

    Athens, 11527, Greece

  • GSK Investigational Site

    Periohi Dragana Alexand, 68100, Greece

  • GSK Investigational Site

    Rio Patras, 26504, Greece

  • GSK Investigational Site

    Kowloon, Hong Kong

  • GSK Investigational Site

    Pokfulam, Hong Kong

  • GSK Investigational Site

    Shatin, Hong Kong

  • GSK Investigational Site

    Budapest, 1097, Hungary

  • GSK Investigational Site

    Eger, 3300, Hungary

  • GSK Investigational Site

    Gyula, 5700, Hungary

  • GSK Investigational Site

    Miskolc, 3530, Hungary

  • GSK Investigational Site

    Belagavi, 590010, India

  • GSK Investigational Site

    Chandigarh, 160012, India

  • GSK Investigational Site

    Chennai, 600113, India

  • GSK Investigational Site

    Coimbatore, 641005, India

  • GSK Investigational Site

    Guhawati, 781006, India

  • GSK Investigational Site

    Hyderabad, 500033, India

  • GSK Investigational Site

    HyderabadTelangana, 500048, India

  • GSK Investigational Site

    Jaipur, 302001, India

  • GSK Investigational Site

    Ludhiana, 141001, India

  • GSK Investigational Site

    Manipal, 576104, India

  • GSK Investigational Site

    Mumbai, 400 008, India

  • GSK Investigational Site

    Mumbai, 400012, India

  • GSK Investigational Site

    Mumbai, 400026, India

  • GSK Investigational Site

    Pune, 411001, India

  • GSK Investigational Site

    Surat, 395002, India

  • GSK Investigational Site

    Brescia, 25123, Italy

  • GSK Investigational Site

    Foggia, 71100, Italy

  • GSK Investigational Site

    Messina, 98124, Italy

  • GSK Investigational Site

    Milan, 20122, Italy

  • GSK Investigational Site

    Milan, 20162, Italy

  • GSK Investigational Site

    Modena, 40126, Italy

  • GSK Investigational Site

    Chiba, 272-8516, Japan

  • GSK Investigational Site

    Ehime, 790-8524, Japan

  • GSK Investigational Site

    Fukuoka, 820-8505, Japan

  • GSK Investigational Site

    Fukuoka, 839-0863, Japan

  • GSK Investigational Site

    Gifu, 500-8717, Japan

  • GSK Investigational Site

    Gifu, 503-8502, Japan

  • GSK Investigational Site

    Hiroshima, 734-8551, Japan

  • GSK Investigational Site

    Hiroshima, 737-0023, Japan

  • GSK Investigational Site

    Hokkaido, 053-8506, Japan

  • GSK Investigational Site

    Hyōgo, 660-8550, Japan

  • GSK Investigational Site

    Kumamoto, 862-8655, Japan

  • GSK Investigational Site

    Miyagi, 980-8574, Japan

  • GSK Investigational Site

    Tokyo, 113-8519, Japan

  • GSK Investigational Site

    Tokyo, 173-8610, Japan

  • GSK Investigational Site

    Tokyo, 180-8610, Japan

  • GSK Investigational Site

    George Town, Malaysia

  • GSK Investigational Site

    Johor Bahru, 80100, Malaysia

  • GSK Investigational Site

    Kota Bharu Kelantan, Malaysia

  • GSK Investigational Site

    Kota Kinabalu, Malaysia

  • GSK Investigational Site

    Kuala Lumpur, Malaysia

  • GSK Investigational Site

    Kuantan, Malaysia

  • GSK Investigational Site

    Guadalajara, 44160, Mexico

  • GSK Investigational Site

    Oaxaca City, 68000, Mexico

  • GSK Investigational Site

    Panama City, 07206, Panama

  • GSK Investigational Site

    Bytom, 41-902, Poland

  • GSK Investigational Site

    Krakow, 31-202, Poland

  • GSK Investigational Site

    Łańcut, 37-100, Poland

  • GSK Investigational Site

    Bucharest, 021105, Romania

  • GSK Investigational Site

    Bucharest, 20125, Romania

  • GSK Investigational Site

    Cluj-Napoca, 400162, Romania

  • GSK Investigational Site

    Iași, 700116, Romania

  • GSK Investigational Site

    Suceava, 720224, Romania

  • GSK Investigational Site

    Timișoara, 300001, Romania

  • GSK Investigational Site

    Singapore, 119074, Singapore

  • GSK Investigational Site

    Singapore, 169608, Singapore

  • GSK Investigational Site

    Ansan, 15355, South Korea

  • GSK Investigational Site

    Busan, 47392, South Korea

  • GSK Investigational Site

    Daegu, 42601, South Korea

  • GSK Investigational Site

    Daegu, 700-721, South Korea

  • GSK Investigational Site

    Seoul, 03080, South Korea

  • GSK Investigational Site

    Seoul, 06351, South Korea

  • GSK Investigational Site

    Seoul, 07061, South Korea

  • GSK Investigational Site

    Seoul, 08308, South Korea

  • GSK Investigational Site

    Barcelona, 08035, Spain

  • GSK Investigational Site

    Barcelona, 08036, Spain

  • GSK Investigational Site

    León, 24080, Spain

  • GSK Investigational Site

    Madrid, 28041, Spain

  • GSK Investigational Site

    Málaga, 29010, Spain

  • GSK Investigational Site

    Salamanca, 37007, Spain

  • GSK Investigational Site

    Santander, 39008, Spain

  • GSK Investigational Site

    Valencia, 46014, Spain

  • GSK Investigational Site

    Valladolid, 47003, Spain

  • GSK Investigational Site

    Vigo, 36002, Spain

  • GSK Investigational Site

    Kaohsiung City, 807, Taiwan

  • GSK Investigational Site

    Kaohsiung City, 833, Taiwan

  • GSK Investigational Site

    Taichung, 40705, Taiwan

  • GSK Investigational Site

    Taipei, 104, Taiwan

  • GSK Investigational Site

    Tau-Yuan, 333, Taiwan

  • GSK Investigational Site

    Bangkok, 10330, Thailand

  • GSK Investigational Site

    Ankara, 06230, Turkey (Türkiye)

  • GSK Investigational Site

    Birmingham, B15 2TH, United Kingdom

  • GSK Investigational Site

    Edinburgh, EH4 2XU, United Kingdom

  • GSK Investigational Site

    Leeds West Yorkshire, LS9 7TF, United Kingdom

  • GSK Investigational Site

    London, SE5 9RS, United Kingdom

  • GSK Investigational Site

    London, SW17 0QT, United Kingdom

Conditions

Explore the condition pages connected to this study.